Quality-Adjusted Life Years Accrued with Cabozantinib in Patients with Advanced Hepatocellular Carcinoma (AHCC) in the CELESTiAL Trial

被引：0

作者：

Venerito, Marino ^{[1
]}

Abou-Alfa, G. K. ^{[2
]}

Mollon, P. ^{[3
]}

Meyer, T. ^{[4
]}

Cheng, A. -L ^{[5
]}

El-Khoueiry, A. B. ^{[6
]}

Kelley, R. K. ^{[7
]}

Baron, A. D. ^{[8
]}

Benzaghou, F. ^{[9
]}

Valcheva, V. ^{[3
]}

Hazra, S. ^{[10
]}

Mangeshkar, M. ^{[10
]}

Freemantle, N. ^{[4
]}

机构：

[1] Univ Klinikum Magdeburg, Magdeburg, Germany

[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[3] Ipsen Pharma SAS, Boulogne, France

[4] UCL, London, England

[5] Staatliche Univ Taiwan, Taipei, Taiwan

[6] Norris Comprehens Canc Ctr, Los Angeles, CA USA

[7] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[8] Calif Pacific Med Ctr, San Francisco, CA USA

[9] Ipsen Innovat, Les Ulis, France

[10] Exelixis Inc, San Francisco, CA USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

174

引用

页码：61 / 61

页数：1

共 50 条

[21] WILLINGNESS TO PAY FOR QUALITY-ADJUSTED LIFE YEARS IN PATIENTS WITH DIABETE
Moradi, N.
Rashidian, A.
VALUE IN HEALTH, 2015, 18 (07) : A617 - A617
[22] Fundamental Measurement and Quality-Adjusted Life Years
Langley, Paul C.
McKenna, Stephen P.
VALUE IN HEALTH, 2021, 24 (03) : 461 - 461
[23] Study of CardioMEMS in heart failure patients: Study confirms benefit in costs and quality-adjusted life years, but does not measure quality-adjusted life years
Messori, Andrea
Trippoli, Sabrina
ESC HEART FAILURE, 2024, 11 (06): : 4437 - 4437
[24] Not all "quality-adjusted life years" are equal
Marra, C. A.
Marion, S. A.
Guh, D. P.
Najafzadeh, M.
Wolfe, F.
Esdaile, J. M.
Clarke, A. E.
Gignac, M. A.
Anis, A. H.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (06) : 616 - 624
[25] Quality-Adjusted Life Years, Quality-Adjusted Life-Year-Like Measures, or Neither? The Debate Continues
Devlin, Nancy J.
Drummond, Michael F.
Mullins, C. Daniel
VALUE IN HEALTH, 2024, 27 (06) : 689 - 691
[26] Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)
Chen, Ronald C.
Choueiri, Toni K.
Feuilly, Marion
Meng, Jie
Lister, Johanna
Marteau, Florence
Falchook, Aaron D.
Morris, Michael J.
George, Daniel J.
Feldman, Darren R.
CANCER, 2020, 126 (24) : 5311 - 5318
[27] Quality-adjusted life years lost in patients with rheumatoid arthritis.
Suarez-Almazor, ME
Popa-Liseanu, MGG
Belseck, EM
Russell, AS
Mallon, C
Kaul, P
ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S328 - S328
[28] THE INTEGRATION OF QUALITY-OF-LIFE AND SURVIVAL - QUALITY-ADJUSTED LIFE YEARS
HAES, JCJM
QUALITY OF LIFE RESEARCH, 1993, 2 (01) : 60 - 60
[29] REGRESSION ESTIMATORS FOR QUALITY OF LIFE AND QUALITY-ADJUSTED LIFE YEARS (QALYS)
Basu, A.
Manca, A.
VALUE IN HEALTH, 2009, 12 (03) : A28 - A29
[30] The quality-adjusted life-years in the oncological patients' health-related quality of life
Kucnerowicz, Karolina
Pietrzak, Agata
Cholewinski, Witold
Martenka, Piotr
Marszalek, Andrzej
Burchardt, Ewa
Strzesak, Erwin
SCIENTIFIC REPORTS, 2022, 12 (01)

← 1 2 3 4 5 →